Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.642885
Title: Assessment of N-myristoyltransferase and the N-myristoylomeas : a potential chemotherapeutic target in Trypanosoma cruzi
Author: Roberts, Adam
ISNI:       0000 0004 5352 9899
Awarding Body: University of Dundee
Current Institution: University of Dundee
Date of Award: 2014
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
As there is a need for fully validated drug targets in Trypanosoma cruzi, the genetic andbiochemical essentiality of N-myristoyltransferase (NMT) was assessed. The geneticrequirement was assessed using a classical gene replacement strategy, attempting tosequentially replace the endogenous alleles with drug resistance genes to generate anNMT null parasite. It was only possible to achieve this in the presence of an ectopiccopy of NMT under constitutive expression, providing the strongest evidence that thisgene is essential for the proliferation of the epimastigote. While both NMT and N-myristoylationwere detected in all lifecycle stages, there were subtle differences in theexpression of several myristoylated proteins. However, at least ~10 myristoylatedproteins were common throughout the lifecycle. In addition, N-myristoylation in thisparasite was found to be primarily associated with nascent protein synthesis, astreatment with cycloheximide reduced the number of N-myristoylated proteins detected. The sensitivity of epimastigotes to the inhibitor DDD85646 correlated with theexpression of NMT, suggesting it to be the target in the parasite. This was confirmedby the dose-dependent depletion of N-myristoylated proteins detected in parasitestreated with this compound. Mechanism of action studies revealed a cytokinesis defectcaused by the inhibition of N-myristoylation and NMT. Overexpression of NMT wasable to rescue these cells from this phenotype confirming that it is NMT mediated. TheN-myristoylated proteins comprising the N-myristoylome of the epimastigote wereidentified using the myristic acid analog, azidomyristate and a chemical proteomicsapproach. Combining label-free and SILAC methodologies, 38 proteins were enrichedfrom azidomyristate labelled cells, 35 of which were predicted to have a glycine afterthe initial methionine. The findings from these experiments have led to the mostcomprehensive N-myristoylome of T. cruzi studied to date and provide severalhypotheses, by which the inhibition of NMT leads to the observed cytokinesis defect.
Supervisor: Fairlamb, Alan Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.642885  DOI: Not available
Keywords: N-myristoyltransferase ; N-myristoylation ; Trypanosoma cruzi ; Chemotherapy ; Proteomics ; click chemistry ; Kinetics
Share: